SENS
insider transactionsSenseonics Holdings, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Cluster buy signal: Multiple insiders at the same company buying around the same time — often a stronger signal than a single buy. 2 different insiders made open-market purchases in the last 365 days, totalling $326.1K.
Net shares · 365d
+57.4K
57.4K buy · 0 sell
Net value · 365d
$326.1K
$326.1K in · $0 out
Sentiment · 365d
Net buying
100% buying · 0% selling
Open-market trades · 365d
3
57.4K buy · 0 sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Other·F
Chief Financial Officer
$38.8K
5.4K sh · $7.18
Own -2%
-
Other·F
Chief Medical Officer
$28.8K
4.0K sh · $7.18
Own -2%
-
Other·F
Chief Operating Officer
$116.3K
16.2K sh · $7.18
Own -3%
-
Other·F
GC & Corp. Development Advisor
$68.5K
9.5K sh · $7.18
Own -3%
-
Other·F
Chief Commercial Officer
$38.9K
5.4K sh · $7.18
Own -4%
-
Other·F
President and CEO
$234.1K
32.6K sh · $7.18
Own -3%
-
Grant·A
Director
$0
13.6K sh
Own New
-
Grant·A
Director
$0
9.9K sh
Own +12%
-
Grant·A
Director
$0
13.6K sh
Own New
-
Grant·A
Director
$0
9.9K sh
Own +7%
-
Grant·A
Director
$0
13.6K sh
Own New
-
Grant·A
Director
$0
9.9K sh
Own +17%
-
Grant·A
Director
$0
13.6K sh
Own New
-
Grant·A
Director
$0
9.9K sh
Own +31%
-
Grant·A
Director
$0
13.6K sh
Own New
-
Grant·A
Director
$0
9.9K sh
Own +13%
-
Grant·A
Director
$0
13.6K sh
Own New
-
Grant·A
Director
$0
9.9K sh
Own +10%
-
Grant·A
Chief Financial Officer
$0
124.2K sh
Own New
-
Grant·A
Chief Financial Officer
$0
90.3K sh
Own +64%
-
Grant·A
Chief Medical Officer
$0
86.9K sh
Own New
-
Grant·A
Chief Medical Officer
$0
63.2K sh
Own +54%
-
Grant·A
Chief Operating Officer
$0
372.6K sh
Own New
-
Grant·A
Chief Operating Officer
$0
270.8K sh
Own +110%
-
Grant·A
GC & Corp. Development Advisor
$0
217.3K sh
Own New
-
Grant·A
GC & Corp. Development Advisor
$0
157.9K sh
Own +115%
-
Grant·A
Chief Commercial Officer
$0
124.2K sh
Own New
-
Grant·A
Chief Commercial Officer
$0
90.3K sh
Own +214%
-
Grant·A
President and CEO
$0
761.9K sh
Own New
-
Grant·A
President and CEO
$0
553.7K sh
Own +89%
-
Other·F
Chief Financial Officer
$52.4K
9.0K sh · $5.82
Own -6%
-
Other·F
Chief Medical Officer
$35.3K
6.1K sh · $5.82
Own -5%
-
Other·F
Chief Operating Officer
$79.6K
13.7K sh · $5.82
Own -5%
-
Other·F
GC & Corp. Development Advisor
$42.6K
7.3K sh · $5.82
Own -5%
-
Other·F
President and CEO
$166.4K
28.6K sh · $5.82
Own -4%
-
Buy·P
Director
$126.1K
22.7K sh · $5.56
Own +19%
-
Grant·A
Director
$12.9K
1.9K sh · $6.65
Own +3%
-
Grant·A
Director
$14.7K
2.2K sh · $6.65
Own +2%
-
Grant·A
Director
$8.1K
1.2K sh · $6.65
Own +2%
-
Grant·A
Director
$14.1K
2.1K sh · $6.65
Own +3%
-
Buy·P
Director
$100.3K
17.5K sh · $5.73
Own +17%
-
Buy·P
President and CEO
$99.7K
17.2K sh · $5.79
Own +3%
-
Grant·A
Director
$12.9K
2.2K sh · $5.89
Own +3%
-
Grant·A
Director
$14.7K
2.5K sh · $5.89
Own +3%
-
Grant·A
Director
$8.1K
1.4K sh · $5.89
Own +2%
-
Grant·A
Director
$14.1K
2.4K sh · $5.89
Own +3%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 15, 2026 | Frederick T. Sullivan KEY | Other F | 5.4K | $38.8K |
| Jun 15, 2026 | Francine Kaufman | Other F | 4.0K | $28.8K |
| Jun 15, 2026 | Mukul Jain | Other F | 16.2K | $116.3K |
| Jun 15, 2026 | Kenneth L Horton | Other F | 9.5K | $68.5K |
| Jun 15, 2026 | Brian B Hansen | Other F | 5.4K | $38.9K |
| Jun 15, 2026 | Timothy T Goodnow KEY | Other F | 32.6K | $234.1K |
| May 20, 2026 | Steven Edelman | Grant A | 13.6K | $0 |
| May 20, 2026 | Steven Edelman | Grant A | 9.9K | $0 |
| May 20, 2026 | Douglas A Roeder | Grant A | 13.6K | $0 |
| May 20, 2026 | Douglas A Roeder | Grant A | 9.9K | $0 |
| May 20, 2026 | Douglas S Prince | Grant A | 13.6K | $0 |
| May 20, 2026 | Douglas S Prince | Grant A | 9.9K | $0 |
| May 20, 2026 | Sharon Larkin | Grant A | 13.6K | $0 |
| May 20, 2026 | Sharon Larkin | Grant A | 9.9K | $0 |
| May 20, 2026 | Edward Fiorentino | Grant A | 13.6K | $0 |
| May 20, 2026 | Edward Fiorentino | Grant A | 9.9K | $0 |
| May 20, 2026 | Stephen P Defalco | Grant A | 13.6K | $0 |
| May 20, 2026 | Stephen P Defalco | Grant A | 9.9K | $0 |
| May 19, 2026 | Frederick T. Sullivan KEY | Grant A | 124.2K | $0 |
| May 19, 2026 | Frederick T. Sullivan KEY | Grant A | 90.3K | $0 |
| May 19, 2026 | Francine Kaufman | Grant A | 86.9K | $0 |
| May 19, 2026 | Francine Kaufman | Grant A | 63.2K | $0 |
| May 19, 2026 | Mukul Jain | Grant A | 372.6K | $0 |
| May 19, 2026 | Mukul Jain | Grant A | 270.8K | $0 |
| May 19, 2026 | Kenneth L Horton | Grant A | 217.3K | $0 |
| May 19, 2026 | Kenneth L Horton | Grant A | 157.9K | $0 |
| May 19, 2026 | Brian B Hansen | Grant A | 124.2K | $0 |
| May 19, 2026 | Brian B Hansen | Grant A | 90.3K | $0 |
| May 19, 2026 | Timothy T Goodnow KEY | Grant A | 761.9K | $0 |
| May 19, 2026 | Timothy T Goodnow KEY | Grant A | 553.7K | $0 |
| May 15, 2026 | Frederick T. Sullivan KEY | Other F | 9.0K | $52.4K |
| May 15, 2026 | Francine Kaufman | Other F | 6.1K | $35.3K |
| May 15, 2026 | Mukul Jain | Other F | 13.7K | $79.6K |
| May 15, 2026 | Kenneth L Horton | Other F | 7.3K | $42.6K |
| May 15, 2026 | Timothy T Goodnow KEY | Other F | 28.6K | $166.4K |
| May 12, 2026 | Douglas A Roeder | Buy P | 22.7K | $126.1K |
| Apr 1, 2026 | Steven Edelman | Grant A | 1.9K | $12.9K |
| Apr 1, 2026 | Douglas A Roeder | Grant A | 2.2K | $14.7K |
| Apr 1, 2026 | Douglas S Prince | Grant A | 1.2K | $8.1K |
| Apr 1, 2026 | Edward Fiorentino | Grant A | 2.1K | $14.1K |
| Mar 13, 2026 | Douglas A Roeder | Buy P | 17.5K | $100.3K |
| Mar 13, 2026 | Timothy T Goodnow KEY | Buy P | 17.2K | $99.7K |
| Jan 2, 2026 | Steven Edelman | Grant A | 2.2K | $12.9K |
| Jan 2, 2026 | Douglas A Roeder | Grant A | 2.5K | $14.7K |
| Jan 2, 2026 | Douglas S Prince | Grant A | 1.4K | $8.1K |
| Jan 2, 2026 | Edward Fiorentino | Grant A | 2.4K | $14.1K |
About SENS insider trading
This page tracks insider transactions for Senseonics Holdings, Inc. (SENS) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.